Kinetic measurements of the hydrolytic degradation of cefixime: Effect of Captisol complexation and water-soluble polymers

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 7, 2008, Pages 833-841

  Mallick, Subrata ^a,c   Mondal, Arijit ^b   Sannigrahi, Santanu ^a  

^a Department of Pharmaceutics   (India)

^b SEEMANTA INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

^c SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN SULFOBUTYL ETHER; CEFIXIME; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; POLYMER; POVIDONE;

ACIDITY; ALKALINITY; ARTICLE; DRUG DEGRADATION; DRUG HYDROLYSIS; DRUG SOLUBILITY; DRUG STABILITY; ENTHALPY; ENTROPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH TEMPERATURE; INFRARED SPECTROSCOPY; KINETICS; MEASUREMENT; STEREOSPECIFICITY; TEMPERATURE SENSITIVITY;

BETA-CYCLODEXTRINS; CEFIXIME; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; KINETICS; POLYMERS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEMPERATURE; THERMODYNAMICS;

EID: 46249112465     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.7.0004     Document Type: Article

References (57)

1. 1 in fatty alcohol propylene glycol ointment by acidic cyclodextrins derivatives O-carboxymethyl-O-ethyl-β-cyclodextrins. Chem. Pharm. Bull. 40: 1586-1591
2. Akaho, E., Fukumori, Y. (2001) Studies on adsorption characteristics and mechanism of adsorption of chlorhexidine mainly by carbon black. J. Pharm. Sci. 90: 1288-1297
3. Al-Marzouqi, A. H., Shehatta, I., Jobe, B., Dowaidar, A. (2006) Phase solubility and inclusion complex of itraconazole with beta-cyclodextrin using supercritical carbon dioxide. J. Pharm. Sci. 95: 292-304
4. Berge, S. M., Henderson, N. L., Frank, M. J. (1983) Kinetics and measurement of degradation of cefotaxime sodium in aqueous solution. J. Pharm. Sci. 72: 59-63
5. Chin, T., Chung, P., Lach, J. L. (1968) Influence of cyclodextrins on ester hydrolysis. J. Pharm. Sci. 57: 44-48
6. Cwiertnia, B., Hladon, T., Stobiecki, M. (1999) Stability of diclofenac sodium in the inclusion complex with β cyclodextrins in the solid state. J. Pharm. Pharmacol. 51: 1213-1218
7. Fabre, H., Eddine, N. H., Berge, G. (1984) Degradation kinetics in aqueous solution of cefotaxime sodium, a third generation cepha-losporin. J. Pharm. Sci. 73: 611-614
8. Forster, A., Hempenstall, J., Rades, T. (2001) Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J. Pharm. Pharmacol. 53:303-315
9. Gekko, K., Ohmae, E., Kameyama, K., Takagi, T. (1998) Acetonitrile-protein interactions: amino acid solubility and preferential solvation. Biochim. Biophys. Acta 1387: 195-205
10. Higuchi, T., Connors, K. A. (1965) Phase solubility techniques. Adv. Anal. Chem. Instrum. 4: 117-212
11. Hirayama, F., Kurihara, M., Uekama, K. (1987) Improvement of chemical stability of prostacyclin in aqueous solution by complex-ation with methylated cyclodextrins. Int. J. Pharm. 35: 193-199
12. Information package (2003) CyDex, Inc., 12980 Metcalf Ave., Suite 470, Overland Park, Kansas 66213, September 16
13. Jumaa, M., Stella, V. J., Chimilio, L., Chinnaswamy, S., Gupta, S. (2001) Preformulation study of an anticancer alkylating agent with poor solubility and solubility properties: Nanosuspensions as a novel alternative formulation. AAPS Annual Meeting and Exposition, Denver, CO, October 21-25
14. Jumaa, M., Chimilio, L., Chinnaswamy, S., Silchenko, S., Stella, V. J. (2004) Degradation of NSC-281612(4-[bis[2-[(methylsulfo-nyl)oxy]ethyl]amino]-2- methylbenzaldehyde), an experimental antineoplastic agent: effects of pH, solvent composition, (SBE)7m-beta-CD, and HP-beta-CD on stability. J. Pharm. Sci. 93: 532-539
15. Kang, J., Kumar, V., Yang, D., Chowdhury, P. R., Hohl, J. (2002) Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent. Eur. J. Pharm. Sci. 15: 163-170
16. Kishinchand, J. L., Manilal, H. M. (2005) Soluble complexes of cefixime and their application to selected pharmaceutical dosage forms. A 61 K 31/545
17. Lach, J. L., Chin, T. (1964) Schardinger dextrin interaction IV. Inhibition of hydrolysis by means of molecular complex formation. J. Pharm. Sci. 53: 924-927
18. Liu, L., Zhu, S. (2006) Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl β-cyclodextrin. J. Pharm. Biotned. Anal. 40: 122-127
19. Loftsson, T., Brewster, M. E. (1996) Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85: 1017-1025
20. Loftsson, T., Frilfriksdottir, H., Sigurlfardottir, A. M., Ueda, H. (1994) The effect of water-soluble polymers on drug cyclodextrins complexation. Int. J. Pharm. 110: 169-177
21. Loftsson, T., Gudmundsdottir, H., Sigurjonsdottir, J. F., Sigurdsson, H. H., Sigfusson, S. D., Masson, M, Stefansson, E. (2001) Cyclodextrin solubilization of benzodiazepines: formulation of mida-zolam nasal spray. Int. J. Pharm. 212: 29-40
22. 7m-β-CD and HP-β-CD on the stability of two anti-neoplastic agents, melphalan and carmustine. J. Pharm. Sci. 89: 275-287
23. Maffeo, D., Leondiadis, L., Mavridis, I. M., Yannakopoulou, K. (2006) Positive effect of natural and negatively charged cyclodextrins on the stabilization of penicillins towards beta-lacta-mase degradation due to inclusion and external guest-host association. An NMR and MS study. Org. Biomol. Chem. 4: 1297-1304
24. Maggi, L., Segale, L., Ochoa, E. M., Buttfava, A., Faucitano, A., Conte, U. (2003) Chemical and physical stability of hydroxypro-pylmethylcellulose matrices containing diltiazem hydrochloride after gamma irradiation. J. Pharm. Sci. 92: 131-141
25. Mallick, S., Pattnaik, S., Swain, K., De, P. K. (2007a) Current perspectives of solubilization: potential for improved bioavailability. Drug Dev. Ind. Pharm. 33: 865-873
26. Mallick, S., Pattnaik, S., Swain, K., De, P. K., Mondal, A., Ghoshal, G., Saha, A. (2007b) Interaction characteristics and thermodynamic behavior of gatifloxacin by aluminium hydroxide. Drug Dev. Ind. Pharm. 33: 535-541
27. Markham, A., Brogden, R. N. (1995) Cefixime: a review of its therapeutic efficacy in lower respiratory tract infection. Drugs 49: 1007-1022
28. Mitra, A. K., Mikkelson, T. J. (1988) Mechanism of transcorneal permeation of pilocarpine. J. Pharm. Sci. 77: 771-775
29. Miyazaki, T., Yoshioka, S., Aso, Y., Kojima, S. (2004) Ability of polyvinyl pyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J. Pharm. Sci. 93: 2710-2717
30. Montay, G., Masala, F., Le, Roux, Y., Le, Liboux, A., Uhlrich, J., Chassard, D., Thebault, J. J., Roche, G., Frydman, A. (1991) Comparative bioavailability study of cefixime administered as tablets or aqueous solution. Drugs 42: 6-9
31. Nagarsenker, M., Meshram, R., Ramprakash, G. (2000) Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats. J. Pharm. Pharmacol. 52: 949-956
32. Namiki, Y., Tanabe, T., Kobayashi, T., Tanabe, J., Okimura, Y., Koda, S., Morimoto, Y. (1987) Degradation kinetics and mechanisms of a new cephalosporin, cefixime, in aqueous solution. J. Pharm. Sci. 76: 208-214
33. Nguyen, N. T., Strickley, R., Jia, W., Lapresca, P., Liu, L., Yu, W., Enriquez, P. M., Palmer, J. T., Spencer, J. R., Mordenti, J. (2001) Formulation strategies at AXYS Pharmaceutical, Inc. for high throughput screening of small molecule compounds. AAPS Annual Meeting and Exposition, Denver, CO, October 21-25
34. Ni, N., Sanghvi, T., Yalkowsky, S. H. (2001) Solubilization of carbendazime. AAPS Annual Meeting and Exposition, Denver, CO, October 21-25
35. Nozaki, Y., Tranford, C. (1963) The solubility of amino acids and related compounds in aqueous urea solutions. J. Biol. Chem. 238: 4074-4080
36. Okamoto, Y., Kiriyama, K., Namiki, Y., Matsushita, J., Fujioka, M., Yasuda, T. (1996a) Degradation kinetics and isomerization of cefdinir, a new oral cephalosporin, in aqueous solution. 2. Hydro-lytic degradation pathway and mechanism for beta-lactam ring opened lactones. J. Pharm. Sci. 85: 984-989
37. Okamoto, Y., Kiriyama, K., Namiki, Y., Matsushita, J., Fujioka, M., Yasuda, T. (1996b) Degradation kinetics and isomerization of cefdinir, a new oral cephalosporin, in aqueous solution. J. Pharm. Sci. 85: 976-983
38. Perry, C. S., Charman, S. A., Prankerd, R. J., Chiu, F. C. K., Scanlon, M. J., Chalmers, D., Charman, W. N. (2006a) Chemical kinetics and aqueous degradation pathways of a new class of synthetic ozonide antimalarials. J. Pharm. Sci. 95: 737-747
39. Perry, C. S., Charman, S. A., Prankerd, R. J., Chiu, F. C. K., Scanlon, M. J., Chalmers, D., Charman, W. N. (2006b) The binding interaction of synthetic ozonide antimalarials with natural and modified beta-cyclodextrins. J. Pharm. Sci. 95: 146-158
40. Porras, S., Sarmini, K., Fanali, S., Kendler, E. (2003) Medium effect (transfer activity coefficient) of methanol and acetonitrile on beta-cyclodextrin/benzoate complexation in capillary zone electro-phoresis. Anal. Chem. 75: 1645-1651
41. Rajewski, R. A., Traiger, G., Bresnahan, J., Jaberaboansari, P., Stella, V. J., Thompson, D. O. (1995) Preliminary safety evaluation of parenterally administered sulfobutyl ether β cyclodextrins derivatives. J. Pharm. Sci. 84: 927-932
42. Rolando, G. H., Lauro, N. P., Laritza, S. M., Miguel, L. L., Joseph, H. (2001) Reversed phase high performance liquid chromatographic determination of cefixime in bulk drugs. J. Liq. Chrom. Rel. Tech. 24: 2315-2324
43. Saarinen-Savolainen, P., Jarvinen, T., Arakisasaki, K., Watanabe, H., Urtti, A. (1998) Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in immortalized human corneal epithelial cell line. Pharm. Res. 15: 1275-1280
44. Stella, V. J., Rajewski, R. A. (1997) Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 14: 556-567
45. Sujimoto, I., Sasaki, K., Kuchiki, A., Ishihara, T., Nakagawa, H. (1982) Stability and bioavailability of nifedipine in fine granules. Chem. Pharm. Bull. 30: 4479-4488
46. Suzuki, H., Sunada, H. (1998) Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem. Pharm. Bull. 46: 482-487
47. Thompson, D. O. (1997) Cyclodextrins enabling excipients: their present and future use in Pharmaceuticals. Crit. Rev. Ther. Drug Carrier Syst. 14: 1-104
48. Totterman, A. M, Schipper, N. G. M, Thompson, D. O., Mannermca, J. P., Kaukonen, A. M. (1997) Intestinal safety of water soluble β cyclodextrins in paediatric oral solution of spironolactone: effects of human intestinal epithelial caco-2 cells. J. Pharm. Pharmacol. 49: 43-48
49. Tsugi, A., Nakashima, E., Deguchi, Y., Nishide, K., Shimizu, T., Horiuchi, S., Ishikawa, K., Yamana, T. (1981) Degradation kinetics and mechanism of aminocephalosporins in aqueous solution: Cefadroxil. J. Pharm. Sci. 70: 1120-1128
50. Tsugi, A., Nakashima, E., Nishide, K,. Deguchi, Y., Horiuchi, S., Yamana, T. (1983) Physiological properties of amphoteric β-lactams antibiotics-III. Stability, solubility and dissolution behavior of cefatrizine and cefadroxil as a function of pH. Chem. Pharm. Bull. 31: 4057-4069
51. Tsuji, A., Miyamoto, E., Yamana, T. (1979) Chemical reactions in cephalosporin allergy: high-pressure liquid chromatographic analysis of cephalosporin aminolysis kinetics. J. Pharm. Sci. 68: 616-621
52. Uekama, K., Hirayama, F., Wakuda, T., Otagi, M. (1981) Effects of cyclodextrins on the hydrolysis of prostacyclin and its methyl ester in aqueous solution. Chem. Pharm. Bull. 29: 213-219
53. Uekama, K., Hieda, Y., Hirayama, F., Arima, A., Sudoh, M., Yagi, A., Terashima, H. (2001) Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin El analogue. Pharm. Res. 18: 1578-1585
54. Usuda, M., Endo, T., Nagase, H., Tomono, K., Ueda, H. (2000) Interaction of antimalarial agent artemisinin with cyclodextrins. Drug Dev. Ind. Pharm. 26: 613-619
55. Werawatganone, P., Wurster, D. (2007) Determination of hydrolysis kinetics of α-naphthyl acetate in micellar systems and the effect of HPMC (catalyst present). J. Pharm. Sci. 96: 448-458
56. Yamana, T., Tsugi, A. (1976) Comparative stability of cepha-losporins in aqueous solution: kinetics and mechanisms of degradation. J. Pharm. Sci. 65: 1563-1574
57. Ziv, G., Lavy, E., Glickman, A., Winkler, M. (1995) Clinical pharmacology of cefixime in unweaned calves. J. Vet. Pharmacol. Ther. 18: 94-100